UBS Lowers Meta Price Target to $715

Jul 30, 2026· 1 min read· Reproduced verbatim
Rating
Buy
Price target
$715
Previous
$766
Implied upside
+22%

UBS analyst Stephen Ju lowered the price target on Meta Platforms Inc.

(NASDAQ: META) to $715 (from $766) while maintaining a Buy rating.

“In our view, not enough credit is being given to Meta’s comments around Business Agents – where usage growing to 1M business accounts within a month of launch tells us demand is there and mgmt. noting that the company will start starting charging (via subscription and volume-based token pricing) in 2H26 suggests monetization will get going.

Meta generally takes about 2-years to ramp revenues on a new product, although given the existing ~400M business account base (per SensorTower) suggests that the timeline could be shorter.

This means 2027 or at latest 2028 revenue could see a step-function increase not reflected in consensus.

We have left our 2026-2028E revenue largely unchanged post print so this would be upside to our estimates as well.

Given Meta formally stated that the contingency plan remains to sell excess compute / model access to external vendors – it would be hard to see a scenario where revenue does not benefit from investments at all.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.